Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
Article in Pharmaceuticals (October 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
Article in Frontiers in Oncology (May 2022)
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
Article in Pharmacological Reviews (January 2022)